US healthcare IT player Cerner has electronic patient records across the Middle East. It is now set to provide services that will enable governments to better control the spread of diabetes. A large contract is in the offing.
We caught up with Filipino hospital operator The Medical City and its plans for the GCC to meet the needs of the millions strong filipino diaspora. It also plans to target low paid workers from other countries.
New ehealth apps mean that the primary care sector in emerging markets can be profitably consolidated for the first time. We look at the potential, talk to advisers, investors and operators look and at what will be delivered in the next six months.
Daniel Antón, the CFO of Dentix, Spain’s largest dental chain with 2016 sales of over €258m, following the 2016 collapse of former leader Vitaldent, speaks to us about its business model in Spain, Italy and Latin America. Unlike the newly reborn Vitaldent, Dentix plans to grab new, apparently high risk, markets outside Spain. How?
In the past two months, SYNLAB, Cerba, Alliance Medical and LifeBrain, four major diagnostic service providers, have strengthened their presence in Italy through the acquisitions of small laboratory/imaging networks. But what is so attractive about Italy?
European laboratory services providers SYNLAB and Cerba are strengthening their position in Italy through the acquisitions of two medical centres networks in the north, in a race to become the main consolidator in the region.
Sanjeev Vashishta, former CEO of SRL, the largest international diagnostic group in India, speaks to us about his plans to build a new lab network, Path Kind, backed by Mankind Pharma Group, which he claims is India’s fourth largest pharmaceutical group.
Romanian healthcare services provider MedLife is buying Bucharest operator Anima, a group of six clinics providing outpatient services to public, private and corporate patients. We speak to Anima’s CEO Cristian Sas.
An offer by the Swiss investor Aevis for the shares of telemedicine group LifeWatch will fail to reach its tender threshold of 67% of controlling equity, say investors.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.